Samuel C. Scott III Net Worth & Insider Trades
Samuel C. Scott III - Director, Abbott Laboratories
What is Samuel C. Scott III's Net Worth?
The current estimated net worth of Abbott Laboratories's Director, Samuel C. Scott III, is estimated to be about $33.65M . Samuel C. Scott III owns about 7,730 units of Abbott Laboratories common stock. In the last 12 years at Abbott Laboratories, Samuel C. Scott III has sold an estimated value of $0 worth.
What is Samuel C. Scott III's Past Insider Trading?
Samuel C. Scott III's largest purchase order was 6,000 units , worth over $337.56K on May 31, 2007. In total, Samuel C. Scott III has made about 25 transactions over 12 years of their time at Abbott Laboratories. Samuel C. Scott III usually trades in April, with the busiest year in 2008 and 2009.
Samuel C. Scott III
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Samuel C. Scott III's' Mailing Address?
- Mailing address is Corn Products International Inc 5 Westbrook Corporate Center Westchester IL 60154 IL
Abbott Laboratories Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
|---|---|---|---|---|---|---|---|---|---|---|
| Robert B. Ford, | 2020 | $20,450,586 | $1,298,462 | $5,623,995 | $5,624,993 | $20,450,586 | $16,549,550 | $77,872 | $20,450,586 | $16,549,550 |
| Robert B. Ford, | 2019 | $11,897,886 | $1,000,000 | $3,475,992 | $3,476,054 | $11,897,886 | $9,777,514 | $71,841 | $11,897,886 | $9,777,514 |
| Robert B. Ford, | 2018 | $8,127,252 | $784,250 | $2,691,621 | $2,691,897 | $8,127,252 | $7,821,493 | $279,213 | $8,127,252 | $7,821,493 |
| Robert E. Funck, Jr., | 2020 | $ | $ | $ | $ | $ | $ | $ | $ | $ |
| Hubert L. Allen, | 2020 | $8,478,177 | $751,346 | $1,874,607 | $1,874,988 | $8,478,177 | $5,919,894 | $154,596 | $8,478,177 | $5,919,894 |
| Hubert L. Allen, | 2019 | $7,486,080 | $710,000 | $2,199,962 | $2,199,990 | $7,486,080 | $6,386,933 | $66,905 | $7,486,080 | $6,386,933 |
| Hubert L. Allen, | 2018 | $7,317,776 | $706,709 | $2,691,621 | $2,691,897 | $7,317,776 | $7,278,480 | $120,316 | $7,317,776 | $7,278,480 |
| John F. Ginascol, | 2020 | $ | $ | $ | $ | $ | $ | $ | $ | $ |
| Daniel G. Salvadori, | 2020 | $5,975,739 | $710,000 | $1,901,708 | $1,902,099 | $5,975,739 | $5,518,569 | $79,421 | $5,975,739 | $5,518,569 |
| Daniel G. Salvadori, | 2019 | $6,767,814 | $704,923 | $2,351,989 | $2,351,986 | $6,767,814 | $6,388,821 | $59,806 | $6,767,814 | $6,388,821 |
| Daniel G. Salvadori, | 2018 | $5,954,210 | $675,038 | $1,993,798 | $1,993,992 | $5,954,210 | $5,907,979 | $434,514 | $5,954,210 | $5,907,979 |
| Miles D. White, | 2020 | $ | $ | $ | $ | $ | $ | $ | $ | $ |
| Miles D. White, | 2019 | $ | $ | $ | $ | $ | $ | $ | $ | $ |
| Miles D. White, | 2018 | $ | $ | $ | $ | $ | $ | $ | $ | $ |
| Brian B. Yoor, | 2020 | $3,489,479 | $207,837 | $1,231,027 | $1,231,237 | $3,489,479 | $2,839,222 | $38,264 | $3,489,479 | $2,839,222 |
| Brian B. Yoor, | 2019 | $9,015,698 | $825,000 | $2,449,976 | $2,449,987 | $9,015,698 | $7,031,097 | $71,331 | $9,015,698 | $7,031,097 |
| Brian B. Yoor, | 2018 | $7,612,836 | $796,057 | $2,691,621 | $2,691,897 | $7,612,836 | $7,280,548 | $73,483 | $7,612,836 | $7,280,548 |
| No matching records found | ||||||||||
Source: https://www.sec.gov/Archives/edgar/data/1800/000104746921000592/a2242988zdef14a.htm
What are Abbott Laboratories's Past Insider Trades?
Abbott Laboratories's most recent insider trade came on January 3, 2023 by Sammy Karam who sold 4,200 units worth $456.75K . In the last 19 years, insiders at Abbott Laboratories have sold an estimated value of $1.77B and bought an estimated value of $1.15B worth of shares. Insider trading is most common in February, with the busiest year in 2009. The most active traders at the company are Miles D White, EXECUTIVE CHAIRMAN, Stephen R Fussell, Executive Vice President, and Robert J Alpern .
ABBOTT LABORATORIES Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||